References
- National Health Service UK. The NHS Cancer Plan. A plan for investment. A plan for reform. 2000. [cited 2022 April 27]. Available from: https://www.thh.nhs.uk/documents/_Departments/Cancer/NHSCancerPlan.pdf.
- Helsedirektoratet. diagnostisk-pakkeforlop-for-pasienter-med-uspesifikke-symptomer-pa-alvorlig-sykdom-som-kan-vaere-kreft [The Norwegian directorate of health. Cancer patient pathway for patient with non specific signs and symptoms of cancer]. cited 2019 November 19]. Available from: https://www.helsedirektoratet.no/pakkeforlop/diagnostisk-pakkeforlop-for-pasienter-med-uspesifikke-symptomer-pa-alvorlig-sykdom-som-kan-vaere-kreft/inngang-til-pakkeforlop-for-pasienter-med-uspesifikke-symptomer. Norwegian.
- Cancercentrum. Allvarliga ospecifika symtom som kan bero på cancer Standardiserat vårdförlopp [Serious non specific symptoms that can be cancer. Standardised cancer patient pathways]. 2018. [cited 2019 November 21]. Available from: https://www.cancercentrum.se/globalassets/vara-uppdrag/kunskapsstyrning/varje-dag-raknas/vardforlopp/kortversioner/pdf/kortversion-svf-allvarliga-ospecifika-symtom-cancer.pdf. Swedish.
- National Institute for Health and Care Excellence (NICE). Referral guidelines for suspected cancer 2005. [cited 2022 April 27]. Available from: https://www.nice.org.uk/guidance/cg27.
- Prades J, Espinàs JA, Font R, et al. Implementing a Cancer Fast-track Programme between primary and specialised care in Catalonia (Spain): a mixed methods study. Br J Cancer. 2011;105(6):1–9. doi: 10.1038/bjc.2011.308.
- New Zealand Ministry of Health. Suspected Cancer in Primary Care: guidelines for investigation, referral and reducing ethnic disparities 2009. [cited 2022 April 27]. Available from: https://www.health.govt.nz/publication/suspected-cancer-primary-care-guidelines-investigation-referral-and-reducing-ethnic-disparities.
- Probst HB, Hussain ZB, Andersen O. Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians–a national Danish project. Health Policy. 2012;105(1):65–70. doi: 10.1016/j.healthpol.2011.11.001.
- Vedsted P, Olesen F. A differentiated approach to referrals from general practice to support early cancer diagnosis - the Danish three-legged strategy. Br J Cancer. 2015;112 Suppl 1(Suppl 1):S65–S69. doi: 10.1038/bjc.2015.44.
- Danish Health Authority. Diagnostisk pakkeforløb for patienter med uspecifikke symptomer på alvorlig sygdom, der kunne være kræft [The cancer patient pathway for patient with non specific signs and symptoms of cancer]. Copenhagen 2016. [Danish]. [cited 2021 June 10]. Available from: https://www.rm.dk/api/NewESDHBlock/DownloadFile?agendaPath=%5C%5CRMAPPS0221.onerm.dk%5CCMS01-EXT%5CESDH%20Data%5CRM_Internet%5Cdagsordener%5CUdvalg_vedroerende_kr%202017%5C18-05-2017%5CAaben_dagsorden&appendixId=163837.
- Virgilsen LF, Møller H, Vedsted PJH. Travel distance to cancer-diagnostic facilities and tumour stage. Health Place. 2019;60:102208. doi: 10.1016/j.healthplace.2019.102208.
- ACE. Key messages from the evaluation of multidisciplinary diagnostic centres (MDC): a new approach to the diagnosis of cancer. 1.1 ed. UK: cancer Research UK; 2019. p. 13.
- Pearson C, Poirier V, Fitzgerald K, et al. Cross-sectional study using primary care and cancer registration data to investigate patients with cancer presenting with non-specific symptoms. BMJ Open. 2020;10(1):e033008. doi: 10.1136/bmjopen-2019-033008.
- Sewell B, Jones M, Gray H, et al. Rapid cancer diagnosis for patients with vague symptoms: a cost-effectiveness study. Br J Gen Pract. 2020;70(692):e186–e192. doi: 10.3399/bjgp20X708077.
- Chapman D, Poirier V, Fitzgerald K, et al. Non-specific symptoms-based pathways for diagnosing less common cancers in primary care: a service evaluation. Br J Gen Pract. 2021;71(712):e846–e853. doi: 10.3399/BJGP.2020.1108.
- Chapman D, Poirier V, Vulkan D, et al. First results from five multidisciplinary diagnostic Centre (MDC) projects for non-specific but concerning symptoms, possibly indicative of cancer. Br J Cancer. 2020;123(5):722–729. doi: 10.1038/s41416-020-0947-y.
- Schmidt M, Schmidt SA, Sandegaard JL, et al. The danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi: 10.2147/CLEP.S91125.
- Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi: 10.1007/s10654-014-9930-3.
- Næser E, Fredberg U, Møller H, et al. Clinical characteristics and risk of serious disease in patients referred to a diagnostic Centre: a cohort study. Cancer Epidemiol. 2017;50(Pt A):158–165. doi: 10.1016/j.canep.2017.07.014.
- Ingeman ML, Christensen MB, Bro F, et al. The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer-a cross-sectional study of patient characteristics and cancer probability. BMC Cancer. 2015;15(1):421. doi: 10.1186/s12885-015-1424-5.
- Moseholm E, Lindhardt BO. Patient characteristics and cancer prevalence in the Danish cancer patient pathway for patients with serious non-specific symptoms and signs of cancer-A nationwide, population-based cohort study. Cancer Epidemiol. 2017;50(Pt A):166–172. doi: 10.1016/j.canep.2017.08.003.
- Jensen E, Kristensen JK, Bjerglund RT, et al. The pathway and characteristics of patients with non-specific symptoms of cancer: a systematic review. BMC Cancer. 2022;22(1):574. doi: 10.1186/s12885-022-09535-y.
- Næser E, Møller H, Fredberg U, et al. Routine blood tests and probability of cancer in patients referred with non-specific serious symptoms: a cohort study. BMC Cancer. 2017;17(1):817. doi: 10.1186/s12885-017-3845-9.
- Møller M, Juvik B, Olesen SC, et al. Diagnostic property of direct referral from general practitioners to contrast-enhanced thoracoabdominal CT in patients with serious but non-specific symptoms or signs of cancer: a retrospective cohort study on cancer prevalence after 12 months. BMJ Open. 2019;9(12):e032019. doi: 10.1136/bmjopen-2019-032019.
- Tørring M. Hvorfor akut kræft? Et bud på en epidemisk forståelse af tid og kræft-tendenser i Danmark. TFSS. 2014;11(20):13–45. Danish. doi: 10.7146/tfss.v11i20.17222.
- Andersen RS, Nichter M, Risør MB. Sensations, symptoms and healthcare seeking. Anthropol in Action. 2017;24(1):1–5. doi: 10.3167/aia.2017.240101.
- Stenman E, Palmér K, Rydén S, et al. Diagnostic spectrum and time intervals in Sweden’s first diagnostic center for patients with nonspecific symptoms of cancer. Acta Oncol. 2019;58(3):296–305. doi: 10.1080/0284186X.2018.1537506.
- Nicholson BD, Oke J, Friedemann Smith C, et al. The Suspected CANcer (SCAN) pathway: protocol for evaluating a new standard of care for patients with non-specific symptoms of cancer. BMJ Open. 2018;8(1):e018168. doi: 10.1136/bmjopen-2017-018168.
- Jørgensen SF, Ravn P, Thorsen S, et al. Characteristics and outcome in patients with non-specific symptoms and signs of cancer referred to a fast track cancer patient pathway; a retrospective cohort study. BMC Cancer. 2017;17(1):809. doi: 10.1186/s12885-017-3826-z.
- O'Sullivan JW, Muntinga T, Grigg S, et al. Prevalence and outcomes of incidental imaging findings: umbrella review. BMJ. 2018;361:k2387. doi: 10.1136/bmj.k2387.
- Murchison AG, Moreland J-A, Gleeson F. Incidental findings in a referral pathway for non-specific cancer symptoms. Clin Imaging. 2021;77:9–12. doi: 10.1016/j.clinimag.2021.01.042.
- Damhus CS, Brodersen JB, Risør MB. Luckily—I am not the worrying kind: experiences of patients in the Danish cancer patient pathway for non-specific symptoms and signs of cancer. Health (London). 2023;27(6):1059–1075. doi: 10.1177/13634593221096244.
- Danish Health Data Authority. Diagnostic pathway for serious disease 1 January 2017–30 June 2018 2019. [cited 2021 May 05]. Available from: https://sundhedsdatastyrelsen.dk/-/media/sds/filer/find-tal-og-analyser/sygdomme-og-behandlinger/alvorlig-sygdom_diagnostisk-pakkeforlob/diagnostiske-pakkeforloeb-2017_2018.pdf.
- Danish Health Authority. Diagnostisk pakkeforløb [Diagnostic pathway]. Copenhagen: danish Health Authority; 2022. [cited 2022 January 24]. Available from: https://www.sst.dk/da/Udgivelser/2022/Diagnostisk-pakkeforloeb.
- Damhus CS. Testing times- Implementation, diagnostic outcomes and the people living beyond the cancer patient pathway for non-specific symptoms and signs of cancer [PhD]. Copenhagen: copenhagen. 2022;22(1):130. doi: 10.1186/s12913-022-07545-x.
- Damhus CS, Siersma V, Dalton SO, et al. Non-specific symptoms and signs of cancer: different organisations of a cancer patient pathway in Denmark. Scand J Prim Health Care. 2021;39(1):23–30. doi: 10.1080/02813432.2021.1880094.
- Damhus CS, Siersma V, Birkmose AR, et al. Colon cancer diagnosed in patients with non-specific symptoms - comparisons between diagnostic paradigms. Acta Oncol. 2023;62(3):272–280. doi: 10.1080/0284186X.2023.2185910.
- Bislev LS, Bruun BJ, Gregersen S, et al. Prevalence of cancer in danish patients referred to a fast-track diagnostic pathway is substantial. Dan Med J. 2015;62(9):1–5.